Article Information
History
- June 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mladen Marinkovic1,
- Suzana Stojanovic-Rundic1,2,
- Aleksandra Stanojevic3,
- Marija Ostojic3,
- Dusica Gavrilovic4,
- Radmila Jankovic3,
- Natasa Maksimovic5,
- Rafael Stroggilos6,
- Jerome Zoidakis6,7,
- Sergi Castellví-Bel8,
- Remond J.A. Fijneman9 and
- Milena Cavic3,*
- 1Clinic for Radiation Oncology and Diagnostics, Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 2Faculty of Medicine, University of Belgrade, Belgrade, Serbia
- 3Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 4Data Center, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 5Institute of Epidemiology, University of Belgrade, Belgrade, Serbia
- 6Department of Biotechnology, Biomedical Research Foundation, Academy of Athens, Athens, Greece
- 7Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
- 8Gastroenterology Department, Fundació Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Clínic Barcelona, University of Barcelona, Barcelona, Spain
- 9Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
- ↵*Corresponding author: Dr Milena Cavic, Institute for Oncology and Radiology of Serbia Department of Experimental Oncology Pasterova 14, 11000 Belgrade, Serbia, Phone number: + 381 11 2067210, Fax number: + 381 11 2067294 E-mail: milena.cavic{at}ncrc.ac.rs
Posted June 22, 2023.
Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
